Canada’s missing life sciences industrial strategy is leaving economic growth on the table
The federal Biomanufacturing and Life Sciences Strategy, released in 2021, did not result in needed policy changes or alignment of federal departments and investments. In contrast, other top-tier countries place life sciences at the centre of industrial strategies and align the sector with talent, trade, research and development, innovation and infrastructure.
Empower hardtech innovators to step up to sovereignty threats
Canada’s radar systems, encryption technologies, and sensors rely heavily on chips produced by foreign suppliers. If a supply chain disruption occurs, this country’s capacity to ensure its security becomes compromised.
Elbow patches up: universities and Canadian sovereignty
At a moment when Canadian values are threatened, universities can be counted on as a key partner in the journey to secure a future of our own design.
When a parliamentary committee recently politicized EDI in research, they put Canadian science and patient care at risk
Equity, diversity, and inclusion policies do not compete with research excellence, but instead strengthen it.
Bill 13 is Alberta’s law—but all Canadians must pay attention
Federal ministers and MPs should clearly reaffirm that equity, diversity, and inclusion are integral to public health, research excellence, and professional regulation—not optional political preferences.
Canada’s EV experience shows why our strategy needs new tools in an age of uncertainty
Strategy carries higher risks when economic, technological, geopolitical shocks are more varied, arrive faster, spread wider, and intersect more than before.
CUSMA must do more than protect trade—it must secure Canada’s life sciences future
The U.S. may begin to apply tariffs or other barriers to enhance its domestic production, and if that happens, Canada will need a plan not just to respond, but also to thrive.
Joly top-lobbied minister in November, universities push to attract research talent driven away from U.S.
U15 Canada CEO Robert Asselin says ‘now is the time to come to Canada and build your career at our world-class research universities.’
Redesigning Canada’s health policy to spur innovation
When patents create an unbalanced system of protection, regulatory exclusivities, which safeguard a firm’s data from being copied by competitors while still allowing scientific collaboration, offer a better alternative.
After America’s Genesis Mission, where is Canada’s AI North Star?
In late November, the White House released an executive order that most Canadians likely missed, buried beneath the flashier political headlines. This announcement of the United States’ Genesis Mission may be remembered as a defining moment in the global race for artificial-intelligence leadership. The executive order reads less like a policy brief and more like […]
